In 2006, Novartis committed US$755 million in company citizenship initiatives world wide, specially concentrating on bettering access to medicines in the acquiring earth by way of its Access to Drugs assignments, which includes donations of medicines to sufferers influenced by leprosy, tuberculosis, and malaria; Glivec patient assistance plans; and